The in vitro Evaluation of the Activity of COVID-19 Antiviral Drugs Against Adenovirus

PURPOSE: Presently, there is no approved antiviral therapy for adenovirus (HAdV) ocular infections. During the COVID-19 pandemic, increased attention has been focused on antiviral treatments. Remdesivir, hydroxychloroquine, ivermectin, and umifenovir (Arbidol) have been touted as potential antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanowski, Eric G, Yates, Kathleen A, Romanowski, John E, Shanks, Robert M Q, Kowalski, Regis P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866980/
https://www.ncbi.nlm.nih.gov/pubmed/35221670
http://dx.doi.org/10.2147/OPTH.S340576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866980/
https://www.ncbi.nlm.nih.gov/pubmed/35221670
http://dx.doi.org/10.2147/OPTH.S340576

Ejemplares similares